Q9HCH5 (SYTL2_HUMAN) Homo sapiens (Human)
Synaptotagmin-like protein 2 UniProtKBInterProSTRINGInteractive Modelling
934 aa; Sequence (Fasta) ; (Isoform 2; Isoform 4; Isoform 6; Isoform 7; Isoform 8; Isoform 9; Isoform 11; Isoform 12; Isoform 13; Isoform 14; Isoform 15)
It is possible new templates exist for this target since these models were created.
Available Structures
8 Experimental Structures
Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
---|---|---|---|---|---|---|
Crystal Structure of the complex Rab27a-Slp2a |
Heteromer Q9ERI2; | 100 | 1×GNP; 1×MG; | |||
Fusion hSlp2-a_Rab27A bound to covalent hit fragment IMP-1721 | homo-2-mer | 100.0 | 2×GNP; 12×GOL; 2×WTK; 2×MG; | |||
Fusion hSlp2-a_Rab27A bound to covalent hit fragment IMP-1704 | homo-2-mer | 100.0 | 7×GOL; 2×GNP; 2×WTU; 2×MG; | |||
Fusion hSlp2-a_Rab27A non-covalent complex with hit fragment IMP-1704 | homo-2-mer | 100.0 | 4×WT6; 2×GNP; 3×GOL; 2×MG; | |||
Rab27a fusion with Slp2a-RBDa1 effector covalent adduct with CA1 in C188 | homo-2-mer | 100.0 | 2×06D; 2×GNP; 2×MG; 8×GOL; | |||
Crystal structure of the Rab27a fusion with Slp2a-RBDa1 effector for SF4 pocket drug targeting | homo-2-mer | 100 | 2×GNP; 2×MG; | |||
Rab27a fusion with Slp2a-RBDa1 effector covalent adduct with CB1 in C123 | homo-2-mer | 100 | 2×GNP; 2×MG; 9×GOL; 2×05Y; | |||
Fusion hSlp2-a_Rab27A non-covalent complex with compound IMP-2505 | homo-2-mer | 100.0 | 2×GNP; 2×WTB; 10×GOL; 2×MG; | |||
5 SWISS-MODEL models
Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
6ank.2.A | monomer | 0.62 | 31.09 | |||
5ccg.1.F | monomer | 0.58 | 29.59 | |||
6mti.1.B | monomer | 0.58 | 29.59 | |||
3hn8.1.A | monomer | 0.57 | 29.04 | |||
1dqv.1.A | monomer | 0.53 | 28.78 | |||